TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NRSN Stock 12 Month Forecast
Average Price Target
$8.25
▲(893.98% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Neurosense Therapeutics Ltd. in the last 3 months. The average price target is $8.25 with a high forecast of $9.00 and a low forecast of $7.50. The average price target represents a 893.98% change from the last price of $0.83.
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -16.50% per trade.
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -22.65% per trade.
Copying Robert LeBoyer's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -22.65% per trade.
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -2.53% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
NRSN Analyst Recommendation Trends
Rating
May 25
Aug 25
Oct 25
Nov 25
Dec 25
Strong Buy
2
2
2
2
3
Buy
0
0
0
0
0
Hold
1
2
2
1
0
Sell
8
2
2
0
0
Strong Sell
0
0
0
0
0
total
11
6
6
3
3
In the current month, NRSN has received 3Buy Ratings, 0Hold Ratings, and 0Sell Ratings. NRSN average Analyst price target in the past 3 months is 8.25.
Each month's total comprises the sum of three months' worth of ratings.
NRSN Financial Forecast
NRSN Earnings Forecast
Next quarter’s earnings estimate for NRSN is -$0.11 with a range of -$0.17 to -$0.04. The previous quarter’s EPS was -$0.04. NRSN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year NRSN has Performed in-line its overall industry.
Next quarter’s earnings estimate for NRSN is -$0.11 with a range of -$0.17 to -$0.04. The previous quarter’s EPS was -$0.04. NRSN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year NRSN has Performed in-line its overall industry.
No data currently available
NRSN Sales Forecast
Next quarter’s sales forecast for NRSN is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were ―. NRSN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year NRSN has Performed in-line its overall industry.
Next quarter’s sales forecast for NRSN is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were ―. NRSN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year NRSN has Performed in-line its overall industry.
NRSN Stock Forecast FAQ
What is NRSN’s average 12-month price target, according to analysts?
Based on analyst ratings, Neurosense Therapeutics Ltd.’s 12-month average price target is 8.25.
What is NRSN’s upside potential, based on the analysts’ average price target?
Neurosense Therapeutics Ltd. has 893.98% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NRSN a Buy, Sell or Hold?
Neurosense Therapeutics Ltd. has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Neurosense Therapeutics Ltd.’s price target?
The average price target for Neurosense Therapeutics Ltd. is 8.25. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $9.00 ,the lowest forecast is $7.50. The average price target represents 893.98% Increase from the current price of $0.83.
What do analysts say about Neurosense Therapeutics Ltd.?
Neurosense Therapeutics Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of NRSN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.